Bank of Nova Scotia’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-39,346
| Closed | -$555K | – | 1001 |
|
|
2024
Q1 | $555K | Sell |
39,346
-1,000
| -2% | -$14.1K | ﹤0.01% | 828 |
|
|
2023
Q4 | $421K | Sell |
40,346
-18,300
| -31% | -$191K | ﹤0.01% | 859 |
|
|
2023
Q3 | $598K | Buy |
58,646
+417
| +0.7% | +$4.25K | ﹤0.01% | 776 |
|
|
2023
Q2 | $438K | Buy |
58,229
+26
| +0% | +$196 | ﹤0.01% | 842 |
|
|
2023
Q1 | $515K | Hold |
58,203
| – | – | ﹤0.01% | 829 |
|
|
2022
Q4 | $531K | Buy |
58,203
+400
| +0.7% | +$3.65K | ﹤0.01% | 903 |
|
|
2022
Q3 | $466K | Hold |
57,803
| – | – | ﹤0.01% | 981 |
|
|
2022
Q2 | $434K | Sell |
57,803
-300
| -0.5% | -$2.25K | ﹤0.01% | 1015 |
|
|
2022
Q1 | $546K | Buy |
58,103
+2,600
| +5% | +$24.4K | ﹤0.01% | 1020 |
|
|
2021
Q4 | $443K | Sell |
55,503
-563
| -1% | -$4.49K | ﹤0.01% | 1064 |
|
|
2021
Q3 | $546K | Buy |
56,066
+750
| +1% | +$7.3K | ﹤0.01% | 928 |
|
|
2021
Q2 | $548K | Buy |
55,316
+2,829
| +5% | +$28K | ﹤0.01% | 915 |
|
|
2021
Q1 | $606K | Sell |
52,487
-365
| -0.7% | -$4.21K | ﹤0.01% | 867 |
|
|
2020
Q4 | $510K | Buy |
52,852
+23,849
| +82% | +$230K | ﹤0.01% | 871 |
|
|
2020
Q3 | $261K | Sell |
29,003
-300
| -1% | -$2.7K | ﹤0.01% | 926 |
|
|
2020
Q2 | $361K | Sell |
29,303
-52,879
| -64% | -$651K | ﹤0.01% | 809 |
|
|
2020
Q1 | $738K | Buy |
82,182
+58,179
| +242% | +$522K | ﹤0.01% | 721 |
|
|
2019
Q4 | $235K | Sell |
24,003
-1,800
| -7% | -$17.6K | ﹤0.01% | 883 |
|
|
2019
Q3 | $178K | Buy |
25,803
+7,800
| +43% | +$53.8K | ﹤0.01% | 873 |
|
|
2019
Q2 | $166K | Hold |
18,003
| – | – | ﹤0.01% | 825 |
|
|
2019
Q1 | $282K | Buy |
18,003
+1,100
| +7% | +$17.2K | ﹤0.01% | 780 |
|
|
2018
Q4 | $261K | Buy |
16,903
+2,800
| +20% | +$43.2K | ﹤0.01% | 777 |
|
|
2018
Q3 | $304K | Buy |
14,103
+1,800
| +15% | +$38.8K | ﹤0.01% | 786 |
|
|
2018
Q2 | $299K | Buy |
+12,303
| New | +$299K | ﹤0.01% | 785 |
|
|
2017
Q3 | – | Sell |
-6,903
| Closed | -$229K | – | 967 |
|
|
2017
Q2 | $229K | Buy |
+6,903
| New | +$229K | ﹤0.01% | 895 |
|
|
2016
Q1 | – | Sell |
-6,334
| Closed | -$419K | – | 723 |
|
|
2015
Q4 | $419K | Buy |
+6,334
| New | +$419K | ﹤0.01% | 495 |
|